This ‘AI TechBio’ company goes public as IPO demand spreads to biotech

6 months ago 26
ARTICLE AD BOX
Shares of Caris Life Sciences soared in their public debut Wednesday, as investors bought into the company’s business of molecular profiling and drug research using artificial intelligence.
Read Entire Article
  1. Homepage
  2. Finance
  3. This ‘AI TechBio’ company goes public as IPO demand spreads to biotech

Related

I’m 57 with $400K in retirement savings and $94K in debt. How do I restructure my loan payments?

I’m 57 with $400K in retirement savings and $94K in debt. Ho...

17 minutes ago 0
He was in the room for Trump’s Venezuela pitch. Now this American oilman says he’s ready to start drilling.

He was in the room for Trump’s Venezuela pitch. Now this Ame...

22 minutes ago 0
Here’s how the housing market can rebound from one of its worst years in decades

Here’s how the housing market can rebound from one of its wo...

1 hour ago 0

Trending

1. wolfsburg vs fc st. pauli
2. the view
3. sénégal – égypte
4. conor gallagher
5. napoli - parma
6. napoli vs parma
7. olympiacos vs paok
8. philadelphia phillies
9. franklin graham call to prayer
10. sundance film festival 2026

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

10 months ago 475
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

10 months ago 429
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

10 months ago 408
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

11 months ago 382
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

11 months ago 336
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2026. All rights are reserved